t
| Date | 1 Dec 2021 |
| Time | 15:00:06 |
| Category | Capital structure |
| ID | 2427U |
1 December 2021 15:00 GMT
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 1 December 2021
|
Name of applicant: |
ASTRAZENECA PLC |
|||
|
Name of scheme: |
ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS-RELATED SHARE OPTION PLAN; ASTRAZENECA ALL-EMPLOYEE SHARE PLAN; ASTRAZENECA PLC 2012 SAVINGS-RELATED SHARE OPTION SCHEME |
|||
|
Period of return: |
From: |
1 JUNE 2021 |
To: |
30 NOVEMBER 2021 |
|
Balance of unallotted securities under scheme(s) from previous return: |
5,252,778 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
65,397 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
5,187,381 |
|||
|
Name of contact: |
Hannah Tattersall |
|
Telephone number of contact: |
+44 (0)746 498 2582 |
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
Contacts
For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.
Adrian Kemp
Company Secretary
AstraZeneca PLC